Inflammation and vascular endothelial activation in an Aboriginal population: Relationships to coronary disease risk factors and nutritional markers

Medical Journal of Australia

Volumn 178, Issue 10, 2003, Pages 495-500

  Rowley, Kevin ^a   Walker, Karen Z ^c,d   Cohen, Jacob ^a,b   Jenkins, Alicia J ^a   O'Neal, David ^a   Su, Qing ^c,e   Best, James D ^a   O'Dea, Kerin ^f  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c MONASH MEDICAL CENTRE   (Australia)

^d MONASH UNIVERSITY   (Australia)

^e Southern Cross Pathology   (Australia)

^f MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTIOXIDANT; BETA CAROTENE; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CAROTENOID; CHOLESTEROL; CRYPTOXANTHIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INSULIN; LYCOPENE; RETINOL; TRIACYLGLYCEROL; XANTHOPHYLL;

ABORIGINE; ADULT; ARTICLE; AUSTRALIA; CELL ACTIVATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DIABETES MELLITUS; DIET; DISEASE MARKER; FEMALE; HEALTH SURVEY; HUMAN; HYPERTENSION; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NUTRITION; NUTRITIONAL PARAMETERS; PREVALENCE; PREVENTIVE MEDICINE; PROTEIN BLOOD LEVEL; RISK FACTOR; VASCULAR ENDOTHELIUM;

EID: 0038474178     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2003.tb05324.x     Document Type: Article

References (30)

1. Gracey M, Williams P, Smith P. Aboriginal deaths in Western Australia: 1985-89 and 1990-94. Aust N Z J Public Health 2000; 24: 145-152.
2. McDermott R, Rowley KG, Lee AJ, et al. Increase in the prevalence of obesity and diabetes and decrease in plasma cholesterol in a central Australian Aboriginal community. Med J Aust 2000; 172: 480-484.
3. Rowley KG, Iser DM, Best JD, et al. Albuminuria in Australian Aboriginal people: Prevalence and associations with components of the metabolic syndrome. Diabetologia 2000; 43: 1394-1403.
4. Madden R. National Aboriginal and Torres Strait Islander Survey 1994. Detailed Findings. Canberra: Australian Bureau of Statistics, 1995.
5. Lee AJ, O'Dea K, Mathews JD. Apparent dietary intake in remote Aboriginal communities. Aust J Public Health 1994; 18: 190-197.
6. Ross R. Mechanisms of disease: Atherosclerosis - An inflammatory disease. N Engl J Med 1999; 340: 115-126.
7. Brown AA, Hu FB. Dietary modulation of endothelial function: Implications for cardiovascular disease. Am J Clin Nutr 2001; 73: 673-686.
8. Ridker PM, Cushman M, Stampfer MJ, et al. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997; 336: 973-979.
9. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342: 836-843.
10. Hwang S-J, Ballantyne CM, Sharrett AR, et al. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. Circulation 1997; 96: 4219-4225.
11. Su Q, Rowley KG, O'Dea K. Stability of individual carotenoids, retinol and tocopherols in human plasma during exposure to light and after extraction. J Chromatogr B Biomed Sci Appl 1999; 729: 191-198.
12. Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: Insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
13. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
14. SPSS for Windows [computer program]. Version 11.0. Chicago, Ill: SPSS Inc, 2002.
15. Strandberg TE, Tilvis RS. C-reactive protein, cardiovascular risk factors, and mortality in a prospective study in the elderly. Arterioscler Thromb Vasc Biol 2000; 20: 1057-1060.
16. Blankenberg S, Rupprecht HJR, Bickel C, et al. Circulating cell adhesion molecules and death in patients with coronary artery disease. Circulation 2001; 104: 1336-1342.
17. Festa A, D'Agostino R, Howard G, et al. Chronic subclinical inflammation as part of the insulin resistance syndrome. The Insulin Resistance Atherosclerosis Study. Circulation 2000; 102: 42-47.
18. Marques-Vidal P, Mazoyer E, Bongard V, et al. Prevalence of insulin resistance syndrome in southwestern France and its relationship with inflammatory and hemostatic markers. Diabetes Care 2002; 25: 1371-1377.
19. Verma S, Wang CH, Li SH, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation 2002; 106: 913-919.
20. Ford E. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 1999; 22: 1971-1977.
21. Geffken DF, Cushman M, Burke GL, et al. Association between physical activity and markers of inflammation in a healthy elderly population. Am J Epidemiol 2001; 153: 242-250.
22. Han TS, Sattar N, Williams K, et al. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City Diabetes Study. Diabetes Care 2002; 25: 2016-2021.
23. Arcaro G, Cretti A, Balzano S, et al. Insulin causes endothelial dysfunction in humans. Sites and mechanisms. Circulation 2002; 105: 576-582.
24. Langlois M, Duprez D, Delanghe J, et al. Serum vitamin C concentration is low in peripheral arterial disease and is associated with inflammation and severity of atherosclerosis. Circulation 2001; 103: 1863-1868.
25. Martin KR, Wu D, Meydani M. The effect of carotenoids on the expression of cell surface adhesion molecules and binding of monocytes to human aortic endothelial cells. Atherosclerosis 2000; 150: 265-274.
26. Spieker LE, Hurlimann D, Ruschitzka F, et al. Mental stress induces prolonged endothelial dysfunction via endothelin-A receptors. Circulation 2002; 105: 2817-2820.
27. Boomsma F, De Kam PJ, Tjeerdsma G, et al. Plasma semicarbazide-sensitive amine oxidase (SSAO) is an independent prognostic marker for mortality in chronic heart failure. Eur Heart J 2000; 21: 1859-1863.
28. De Boer OJ, Van Der Wal AC, Becker AE. Atherosclerosis, inflammation and infarction. J Pathol 2000; 190: 237-243.
29. Lee AJ, Bonson APV, Yarmirr D, et al. Sustainability of a successful health and nutrition program in a remote Aboriginal community. Med J Aust 1995; 162: 632-635.
30. Rowley KG, Qing S, Cincotta M, et al. Improvements in circulating cholesterol, antioxidants and homocysteine following dietary intervention in an Australian Aboriginal community. Am J Clin Nutr 2001; 74: 442-448.